TK
Thangavelu Kalavathi
About Thangavelu Kalavathi
Data last updated:
Thangavelu Kalavathi is a Director at Abirami Kidney Care Private Limited (since 2022), Additional Director at Sree Ss Pharma Private Limited (since 2022) and Director at Resante Life Sciences Private Limited (since 2020), and holds 2 more current directorships. The companies operate in Healthcare, Pharma and Trading. The 4 current companies with reported revenue have a combined latest revenue of ₹24.97 Cr; the largest is Abirami Kidney Care Private Limited at ₹11.63 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Abirami Kidney Care Private Limited U93000TZ2019PTC031494 | Director | 16 Apr 2022 | 2019 | ₹11.63 Cr (FY 2025) | Active |
 Sree Ss Pharma Private Limited U51909TZ2019PTC033203 | Additional Director | 16 Apr 2022 | 2019 | ₹7.51 Cr (FY 2025) | Active |
| Resante Life Sciences Private Limited U51909TN2020PTC136160 | Director | 09 Dec 2020 | 2020 | ₹4.25 Cr (FY 2025) | Active |
| Four Square Medical Centre And Hospital Private Limited U85300TZ2021PTC036906 | Director | 19 Aug 2022 | 2021 | ₹1.58 Cr (FY 2025) | Active |
| Sri Lalitham Realty Services Private Limited U68100TZ2025PTC034213 | Director | 03 Apr 2025 | 2025 | Active |
Board colleagues of Thangavelu Kalavathi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jambai Munirajah Jayaprakash | 02066229 | Abirami Kidney Care Private Limited | Additional Director |
| Thangavelu Saravanan | 08325439 | Abirami Kidney Care Private Limited , Sree Ss Pharma Private Limited and 2 more | Director |
| Elangovan Girija | 08781202 | Resante Life Sciences Private Limited | Director |
| Muthugounder Chindamani | 08985853 | Resante Life Sciences Private Limited | Director |
| Paramasivam Lavanya | 08984610 | Resante Life Sciences Private Limited | Director |
| Sangeetha | 08781223 | Resante Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Thangavelu Kalavathi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thangavelu Kalavathi
Thangavelu Kalavathi currently holds 5 directorships: Abirami Kidney Care Private Limited (Director, since 16 Apr 2022, revenue ₹11.63 Cr (FY 2025)); Sree Ss Pharma Private Limited (Additional Director, since 16 Apr 2022, revenue ₹7.51 Cr (FY 2025)); Resante Life Sciences Private Limited (Director, since 09 Dec 2020, revenue ₹4.25 Cr (FY 2025)); Four Square Medical Centre And Hospital Private Limited (Director, since 19 Aug 2022, revenue ₹1.58 Cr (FY 2025)); Sri Lalitham Realty Services Private Limited (Director, since 03 Apr 2025).
Thangavelu Kalavathi was first appointed on 09 Dec 2020 as Director at Resante Life Sciences Private Limited. The most recent appointment on record is 03 Apr 2025 at Sri Lalitham Realty Services Private Limited.
The 4 current companies of Thangavelu Kalavathi that report revenue have a combined latest revenue of ₹24.97 Cr: Abirami Kidney Care Private Limited ₹11.63 Cr (FY 2025); Sree Ss Pharma Private Limited ₹7.51 Cr (FY 2025); Resante Life Sciences Private Limited ₹4.25 Cr (FY 2025); Four Square Medical Centre And Hospital Private Limited ₹1.58 Cr (FY 2025).
The current boards of Thangavelu Kalavathi's companies include Jambai Munirajah Jayaprakash (Abirami Kidney Care Private Limited), Thangavelu Saravanan (Abirami Kidney Care Private Limited), Elangovan Girija (Resante Life Sciences Private Limited), Muthugounder Chindamani (Resante Life Sciences Private Limited), Paramasivam Lavanya (Resante Life Sciences Private Limited), Sangeetha (Resante Life Sciences Private Limited).